What are the side effects of Quizartinib?

Quizatinib is a treatment for patients with acute myeloid leukemia (AML) who have a specific genetic mutationFLT3-ITD. While it holds promise for improving outcomes for these patients, understanding its potential side effects is critical for patients and health care providers.

First, heart problems are one of the most worrisome side effects of Quizartinib. In particular, the QT interval is prolonged, a measurement on the electrocardiogram (ECG) that reflects the time it takes for the heart's electrical system to reset. QT prolongation may lead to torsade de pointes, a potentially life-threatening condition. Therefore, regular ECG monitoring is essential to reduce this risk.

Secondly, bone marrow suppression is also a common side effect in patients taking quizartinib hydrochloride. This results in reduced blood cell production, leading to symptoms such as anemia, neutropenia, and thrombocytopenia. Patients may feel fatigued, be more susceptible to infections, and bruise or bleed easily. Regular blood tests are essential to monitor blood cell levels and manage these risks.

In addition, gastrointestinal problems are also one of the common side effects of quizartinib hydrochloride. Patients may experience nausea, vomiting, diarrhea, and abdominal pain. These symptoms can often be controlled with supportive care medications, but can still impact the patient's quality of life.

Hepatotoxicity is also a potential side effect of quizartinib hydrochloride. Elevated liver enzymes may indicate liver damage, and patients may experience symptoms such as jaundice (yellowing of the skin and eyes), dark urine, and abdominal pain. Therefore, routine liver function tests are recommended to detect signs of hepatotoxicity early and to adjust drug dosage if necessary.

In addition to the side effects listed above, quizartinib hydrochloride may cause skin reactions such as rash, dry skin, and itching. These symptoms may be mild or severe and may require topical treatment or dosage adjustment to relieve symptoms.

Fatigue is also a common side effect of quizartinib hydrochloride. This may be due to a combination of factors, including the drug's impact on blood counts, the gastrointestinal system, and the overall burden of cancer treatment. Managing fatigue requires a holistic approach that includes nutritional support, tolerable exercise, and adequate rest.

In some cases, patients may develop electrolyte imbalances while taking quizartinib hydrochloride. These imbalances can affect various body functions and may require monitoring and correction through dietary modifications or supplements.

Although less common, some patients may also experience hypersensitivity reactions, such as anaphylaxis. Symptoms include rash, itching, swelling and, in severe cases, difficulty breathing. If any signs of a serious allergic reaction occur, seek immediate medical attention.

In conclusion, it is critical for patients taking quizartinib hydrochloride to maintain open communication with their healthcare team. Side effects vary from person to person, and early detection and management is key to minimizing their impact. By closely monitoring side effects and working closely with their healthcare provider, patients can manage these risks and optimize treatment outcomes.

xa0

Reference: https://synapse.patsnap.com/article/what-are-the-side-effects-of-quizartinib-hydrochloride